E
Elisabeth Haschke-Becher
Researcher at Paracelsus Private Medical University of Salzburg
Publications - 90
Citations - 2033
Elisabeth Haschke-Becher is an academic researcher from Paracelsus Private Medical University of Salzburg. The author has contributed to research in topics: Natalizumab & Medicine. The author has an hindex of 22, co-authored 86 publications receiving 1679 citations.
Papers
More filters
Journal ArticleDOI
Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver
Alexandra Feldman,Sebastian K. Eder,Thomas K. Felder,Lyudmyla Kedenko,Bernhard Paulweber,Andreas Stadlmayr,Ursula Huber-Schönauer,David Niederseer,Felix Stickel,Simon Auer,Elisabeth Haschke-Becher,Wolfgang Patsch,Christian Datz,Elmar Aigner +13 more
TL;DR: Lean subjects with evidence of NAFLD have clinically relevant impaired glucose tolerance, low adiponectin concentrations and a distinct metabolite profile with an increased rate of PNPLA3 risk allele carriage.
Journal ArticleDOI
Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendations.
Olaf Stanger,Brian Fowler,Klaus Piertzik,Martina Huemer,Elisabeth Haschke-Becher,Alexander Semmler,Stefan Lorenzl,Michael Linnebank +7 more
TL;DR: Evidence regarding whether substitution of folate and vitamin B12 is beneficial, for example, in cerebrovascular disease, dementia and depression is reviewed, with particular emphasis on the evidence for prophylactic and therapeutic strategies.
Journal ArticleDOI
Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design
Rianne M F van Schie,Mia Wadelius,Farhad Kamali,Ann K. Daly,Vangelis G. Manolopoulos,Anthonius de Boer,Rita Barallon,Talitha I. Verhoef,Julia Kirchheiner,Elisabeth Haschke-Becher,Montserrat Briz,Frits R. Rosendaal,William K. Redekop,Munir Pirmohamed,Anke-Hilse Maitland-van der Zee +14 more
TL;DR: The European Pharmacogenetics of Anticoagulant Therapy (EU-PACT) trial will assess, in a single-blinded and randomized controlled trial with a follow-up period of 3 months, the safety and clinical utility of genotype-guided dosing in daily practice for the three main coumarin derivatives used in Europe.
Journal ArticleDOI
The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2 , CBL and KRAS mutations by an international consortium involving 10 laboratories
Alexander Kohlmann,Hans-Ulrich Klein,Sandra Weissmann,Silvia Bresolin,Tracy Chaplin,Harry Cuppens,Elisabeth Haschke-Becher,Bernardo Garicochea,Vera Grossmann,Bozena Hanczaruk,Katja Hebestreit,Christian Gabriel,Ilaria Iacobucci,Joop H. Jansen,G te Kronnie,L. T. F. Van De Locht,Giovanni Martinelli,Kim R. McGowan,Michal R. Schweiger,Bernd Timmermann,Peter Vandenberghe,Bryan D. Young,Martin Dugas,T Haferlach +23 more
TL;DR: This multicenter analysis demonstrated that amplicon-based deep sequencing is technically feasible, achieves high concordance across multiple laboratories and allows a broad and in-depth molecular characterization of cancer specimens with high diagnostic sensitivity.
Journal ArticleDOI
Does maternal docosahexaenoic acid supplementation during pregnancy and lactation lower BMI in late infancy
Renate L. Bergmann,Karl E. Bergmann,Elisabeth Haschke-Becher,Rolf Richter,Joachim W. Dudenhausen,Denis Barclay,Ferdinand Haschke +6 more
TL;DR: It is indicated that DHA taken by pregnant and lactating mothers may reduce BMI in late infancy, and a significant time dependent effect for the DHA group on the development of the body mass index (BMI) is shown.